Proceedings of the National Academy of Sciences · 1980 · 180 citations · 23 references
MedicineBiochemistryOphthalmologyGlycobiologyOcular PathologyOphthalmic PathologyCorneal DiseaseCorneal DisordersCorneal PathologyCorneal PhysiologyGlycan BiosynthesisGlycan StructureChondroitin Sulfate BiosynthesisCorneal Dystrophy PathogenesisGlycoprotein LabelingKeratan Sulfate BiosynthesisOpacityProteoglycan Metabolism
Corneal specimens obtained during surgery from patients with macular corneal dystrophy and obtained at autopsy from control eyes were incubated in a medium containing radioactive precursors of glycoproteins and proteoglycans. Biosynthetically radiolabeled material was extracted and characterized by using molecular sieve chromatography and specific enzymes. Cells in control corneas synthesized both a chondroitin sulfate proteoglycan and a keratan sulfate proteoglycan similar to those present in monkey and bovine corneas. Cells in macular corneas synthesized a normal chondroitin sulfate proteoglycan but did not synthesize either keratan sulfate or a mature keratan sulfate proteoglycan. Instead, macular corneas synthesized a glycoprotein with unusually large oligosaccharide side chains. This glycoprotein was not detected in normal corneas and is slightly smaller than normal keratan sulfate proteoglycan. The failure to synthesize a mature keratan sulfate proteoglycan may produce corneal opacity and result in blindness. Because of evidence indicating that the corneal keratan sulfate proteoglycan is normally synthesized through a glycoprotein intermediate [Hart, G. W. & Lennarz, W. (1978) J. Biol. Chem. 253-5795-5801], macular corneal dystrophy may be a defect in glycoprotein processing.
23
Ira Tabas, Sondra Schlesinger, Stuart Kornfeld · Journal of Biological Chemistry · 1978 · 358 citations · Full text
Stuart Kornfeld, E. Li, Ira Tabas · Journal of Biological Chemistry · 1978 · 334 citations · Full text